AU2003218713A1 - Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7) - Google Patents

Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7)

Info

Publication number
AU2003218713A1
AU2003218713A1 AU2003218713A AU2003218713A AU2003218713A1 AU 2003218713 A1 AU2003218713 A1 AU 2003218713A1 AU 2003218713 A AU2003218713 A AU 2003218713A AU 2003218713 A AU2003218713 A AU 2003218713A AU 2003218713 A1 AU2003218713 A1 AU 2003218713A1
Authority
AU
Australia
Prior art keywords
gpr7
therapeutics
diagnostics
protein
homo sapiens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218713A
Other versions
AU2003218713A8 (en
Inventor
Ulf Bruggemeier
Andreas Geerts
Stefan Golz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003218713A1 publication Critical patent/AU2003218713A1/en
Publication of AU2003218713A8 publication Critical patent/AU2003218713A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU2003218713A 2002-03-22 2003-03-10 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7) Abandoned AU2003218713A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02006594 2002-03-22
EP02006594.2 2002-03-22
PCT/EP2003/002404 WO2003080097A2 (en) 2002-03-22 2003-03-10 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7)

Publications (2)

Publication Number Publication Date
AU2003218713A1 true AU2003218713A1 (en) 2003-10-08
AU2003218713A8 AU2003218713A8 (en) 2003-10-08

Family

ID=28051728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003218713A Abandoned AU2003218713A1 (en) 2002-03-22 2003-03-10 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7)

Country Status (2)

Country Link
AU (1) AU2003218713A1 (en)
WO (1) WO2003080097A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080485A1 (en) * 2003-03-13 2004-09-23 Takeda Pharmaceutical Company Preventive/remedy for diseases in upper digestive tract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591602A (en) * 1993-11-05 1997-01-07 O'dowd; Brian F. Nucleic acid encoding opioid receptor
WO2001059113A2 (en) * 2000-02-08 2001-08-16 Curagen Corporation G-protein coupled receptor proteins and nucleic acids encoding same
AU2001273167A1 (en) * 2000-06-30 2002-01-14 Curagen Corporation G-protein coupled receptors and nucleic acids encoding same

Also Published As

Publication number Publication date
WO2003080097A3 (en) 2004-03-11
AU2003218713A8 (en) 2003-10-08
WO2003080097A2 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
AU2003244637A1 (en) Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr)
AU2003218713A1 (en) Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003212356A1 (en) Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8)
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003227065A1 (en) Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 63 (gpr63)
AU2003229767A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003273994A1 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003288251A1 (en) Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor 38 (gpr38)
AU2003218716A1 (en) Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2
AU2003298111A1 (en) Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37)
AU2003216866A1 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
AU2003238174A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 3 (sstr3)
AU2003227751A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
AU2003240639A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
AU2003301991A1 (en) Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5)
AU2003276106A8 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003287976A1 (en) Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 3 (edg3)
AU2003266238A1 (en) Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1)
AU2003276097A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
AU2003283266A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14)
AU2003301892A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase